Literature DB >> 10955771

Can O6-alkylguanine-DNA alkyltransferase depletion enhance alkylator activity in the clinic?

H S Friedman.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10955771

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  5 in total

1.  Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients.

Authors:  Antonio Silvani; Elena Lamperti; Paola Gaviani; Marica Eoli; Anna Fiumani; Andrea Salmaggi; Chiara Falcone; Graziella Filippini; Andrea Botturi; Amerigo Boiardi
Journal:  J Neurooncol       Date:  2007-06-19       Impact factor: 4.130

2.  Temozolomide in malignant glioma.

Authors:  Gregor Dresemann
Journal:  Onco Targets Ther       Date:  2010-09-07       Impact factor: 4.147

3.  Alkylation damage repair protein O6-alkylguanine-DNA alkyltransferase from the hyperthermophiles Aquifex aeolicus and Archaeoglobus fulgidus.

Authors:  Sreenivas Kanugula; Anthony E Pegg
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

4.  Current available therapies and future directions in the treatment of malignant gliomas.

Authors:  Annick Desjardins; David A Reardon; James J Vredenburgh
Journal:  Biologics       Date:  2009-07-13

5.  miR-29c contribute to glioma cells temozolomide sensitivity by targeting O6-methylguanine-DNA methyltransferases indirectely.

Authors:  Songhua Xiao; Zhen Yang; Xingsheng Qiu; Ruiyan Lv; Jun Liu; Ming Wu; Yiwei Liao; Qing Liu
Journal:  Oncotarget       Date:  2016-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.